Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase

Journal of General Virology

Volumn 92, Issue 1, 2011, Pages 101-111

  Mousseau, G ^a   Kota, S ^a   Takahashi, V ^a   Frick, D N ^b   Strosberg, A D ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; FAT DROPLET; HELICASE; MONTIRELIN; NONSTRUCTURAL PROTEIN 3; VIRUS PROTEIN;

ARTICLE; BUDDING; CARBOXY TERMINAL SEQUENCE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CROSS LINKING; DIMERIZATION; HEPATITIS C VIRUS; HEPATOMA CELL; MACROMOLECULE; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN INTERACTION; REPLICON; VIRUS CORE; VIRUS INFECTIVITY; VIRUS PARTICLE;

CELL LINE; HEPATOCYTES; HUMANS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN MULTIMERIZATION; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; MIRIDAE;

EID: 78651249671     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.023325-0     Document Type: Article

References (53)

1. Alter, M. J. (2007). Epidemiology of hepatitis C virus infection. World J Gastroenterol 13, 2436-2441.
2. Angus, A. G., Dalrymple, D., Boulant, S., McGivern, D. R., Clayton, R. F., Scott, M. J., Adair, R., Graham, S., Owsianka, A. M. & other authors (2010). Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein. J Gen Virol 91, 122-132.
3. Appel, N., Zayas, M., Miller, S., Krijnse-Locker, J., Schaller, T., Friebe, P., Kallis, S., Engel, U. & Bartenschlager, R. (2008). Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 4, e1000035.
4. Belon, C. A. & Frick, D. N. (2008). Monitoring helicase activity with molecular beacons. Biotechniques 45, 433-440, 442.
5. Boulant, S., Vanbelle, C., Ebel, C., Penin, F. & Lavergne, J. P. (2005). Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features. J Virol 79, 11353-11365.
6. Boulant, S., Montserret, R., Hope, R. G., Ratinier, M., Targett-Adams, P., Lavergne, J. P., Penin, F. & McLauchlan, J. (2006). Structural determinants that target the hepatitis C virus core protein to lipid droplets. J Biol Chem 281, 22236-22247.
7. Chen, W., Zhang, Z., Chen, J., Zhang, J., Zhang, J., Wu, Y., Huang, Y., Cai, X. & Huang, A. (2008). HCV core protein interacts with Dicer to antagonize RNA silencing. Virus Res 133, 250-258.
8. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
9. Frick, D. N., Rypma, R. S., Lam, A. M. & Gu, B. (2004). The nonstructural protein 3 protease/helicase requires an intact protease domain to unwind duplex RNA efficiently. J Biol Chem 279, 1269-1280.
10. Gallinari, P., Brennan, D., Nardi, C., Brunetti, M., Tomei, L., Steinkuhler, C. & De Francesco, R. (1998). Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J Virol 72, 6758-6769.
11. Jirasko, V., Montserret, R., Appel, N., Janvier, A., Eustachi, L., Brohm, C., Steinmann, E., Pietschmann, T., Penin, F. & Bartenschlager, R. (2008). Structural and functional characterization of nonstructural protein 2 for its role in hepatitis C virus assembly. J Biol Chem 283, 28546-28562.
12. Jones, C. T., Murray, C. L., Eastman, D. K., Tassello, J. & Rice, C. M. (2007). Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J Virol 81, 8374-8383.
13. Jones, D. M., Patel, A. H., Targett-Adams, P. & McLauchlan, J. (2009). The hepatitis C virus NS4B protein can trans-complement viral RNA replication and modulates production of infectious virus. J Virol 83, 2163-2177.
14. Klein, K. C., Polyak, S. J. & Lingappa, J. R. (2004). Unique features of hepatitis C virus capsid formation revealed by de novo cell-free assembly. J Virol 78, 9257-9269.
15. Kota, S., Coito, C., Mousseau, G., Lavergne, J. P. & Strosberg, A. D. (2009). Peptide inhibitors of hepatitis C virus core oligomerization and virus production. J Gen Virol 90, 1319-1328.
16. Kota, S., Scampavia, L., Spicer, T., Beeler, A. B., Takahashi, V., Snyder, J. K., Porco, J. A., Hodder, P. & Strosberg, A. D. (2010). A time-resolved fluorescence-resonance energy transfer assay for identifying inhibitors of hepatitis C virus core dimerization. Assay Drug Dev Technol 8, 96-105.
17. Kunkel, M., Lorinczi, M., Rijnbrand, R., Lemon, S. M. & Watowich, S. J. (2001). Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein. J Virol 75, 2119-2129.
18. Lam, A. M., Keeney, D., Eckert, P. Q. & Frick, D. N. (2003). Hepatitis C virus NS3 ATPases/helicases from different genotypes exhibit variations in enzymatic properties. J Virol 77, 3950-3961.
19. Lavanchy, D. (2009). The global burden of hepatitis C. Liver Int 29 (Suppl. 1), 74-81.
20. Lindenbach, B. D., Evans, M. J., Syder, A. J., Wolk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R. & other authors (2005). Complete replication of hepatitis C virus in cell culture. Science 309, 623-626.
21. Ma, Y., Yates, J., Liang, Y., Lemon, S. M. & Yi, M. (2008). NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol 82, 7624-7639.
22. Mamiya, N. & Worman, H. J. (1999). Hepatitis C virus core protein binds to a DEAD box RNA helicase. J Biol Chem 274, 15751-15756.
23. Masaki, T., Suzuki, R., Murakami, K., Aizaki, H., Ishii, K., Murayama, A., Date, T., Matsuura, Y., Miyamura, T. & other authors (2008). Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol 82, 7964-7976.
24. Matsumoto, M., Hwang, S. B., Jeng, K. S., Zhu, N. & Lai, M. M. (1996). Homotypic interaction and multimerization of hepatitis C virus core protein. Virology 218, 43-51.
25. McLauchlan, J. (2000). Properties of the hepatitis C virus core protein: a structural protein that modulates cellular processes. J Viral Hepat 7, 2-14.
26. McLauchlan, J. (2009a). Hepatitis C virus: viral proteins on the move. Biochem Soc Trans 37, 986-990.
27. McLauchlan, J. (2009b). Lipid droplets and hepatitis C virus infection. Biochim Biophys Acta 1791, 552-559.
28. McLauchlan, J., Lemberg, M. K., Hope, G. & Martoglio, B. (2002). Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets. EMBO J 21, 3980-3988.
29. Miyanari, Y., Atsuzawa, K., Usuda, N., Watashi, K., Hishiki, T., Zayas, M., Bartenschlager, R., Wakita, T., Hijikata, M. & Shimotohno, K. (2007). The lipid droplet is an important organelle for hepatitis C virus production. Nat Cell Biol 9, 1089-1097.
30. Moradpour, D., Penin, F. & Rice, C. M. (2007). Replication of hepatitis C virus. Nat Rev Microbiol 5, 453-463.
31. Murray, C. L., Jones, C. T., Tassello, J. & Rice, C. M. (2007). Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus. J Virol 81, 10220-10231.
32. Murray, C. L., Jones, C. T. & Rice, C. M. (2008). Architects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesis. Nat Rev Microbiol 6, 699-708.
33. Nolandt, O., Kern, V., Muller, H., Pfaff, E., Theilmann, L., Welker, R. & Krausslich, H. G. (1997). Analysis of hepatitis C virus core protein interaction domains. J Gen Virol 78, 1331-1340.
34. Owsianka, A. M. & Patel, A. H. (1999). Hepatitis C virus core protein interacts with a human DEAD box protein DDX3. Virology 257, 330-340.
35. Patkar, C. G. & Kuhn, R. J. (2008). Yellow fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J Virol 82, 3342-3352.
36. Penin, F., Dubuisson, J., Rey, F. A., Moradpour, D. & Pawlotsky, J. M. (2004). Structural biology of hepatitis C virus. Hepatology 39, 5-19.
37. Pietschmann, T., Kaul, A., Koutsoudakis, G., Shavinskaya, A., Kallis, S., Steinmann, E., Abid, K., Negro, F., Dreux, M. & other authors (2006). Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc Natl Acad Sci U S A 103, 7408-7413.
38. Rouille, Y., Helle, F., Delgrange, D., Roingeard, P., Voisset, C., Blanchard, E., Belouzard, S., McKeating, J., Patel, A. H. & other authors (2006). Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol 80, 2832-2841.
39. Sakamoto, N. & Watanabe, M. (2009). New therapeutic approaches to hepatitis C virus. J Gastroenterol 44, 643-649.
40. Shavinskaya, A., Boulant, S., Penin, F., McLauchlan, J. & Bartenschlager, R. (2007). The lipid droplet binding domain of hepatitis C virus core protein is a major determinant for efficient virus assembly. J Biol Chem 282, 37158-37169.
41. Shi, S. T., Polyak, S. J., Tu, H., Taylor, D. R., Gretch, D. R. & Lai, M. M. (2002). Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. Virology 292, 198-210.
42. Steinmann, E., Penin, F., Kallis, S., Patel, A. H., Bartenschlager, R. & Pietschmann, T. (2007). Hepatitis C virus p7 protein is crucial for assembly and release of infectious virions. PLoS Pathog 3, e103.
43. Strosberg, A. D., Kota, S., Takahashi, V., Snyder, J. K. & Mousseau, G. (2010). Core as a novel target for hepatitis C drugs. Viruses 2, 1734-1751.
44. Tan, S. L., Pause, A., Shi, Y. & Sonenberg, N. (2002). Hepatitis C therapeutics: current status and emerging strategies. Nat Rev Drug Discov 1, 867-881.
45. Tellinghuisen, T. L., Foss, K. L. & Treadaway, J. (2008). Regulation of hepatitis C virion production via phosphorylation of the NS5A protein. PLoS Pathog 4, e1000032.
46. Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Krausslich, H. G. & other authors (2005). Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-796.
47. Wei, W., Cai, C., Kota, S., Takahashi, V., Ni, F., Strosberg, A. D. & Snyder, J. K. (2009). New small molecule inhibitors of hepatitis C virus. Bioorg Med Chem Lett 19, 6926-6930.
48. Wu, J., Bera, A. K., Kuhn, R. J. & Smith, J. L. (2005). Structure of the Flavivirus helicase: implications for catalytic activity, protein interactions, and proteolytic processing. J Virol 79, 10268-10277.
49. Yan, X. B., Battaglia, S., Boucreux, D., Chen, Z., Brechot, C. & Pavio, N. (2007). Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR. Virus Res 125, 79-87.
50. Yi, M., Ma, Y., Yates, J. & Lemon, S. M. (2007). Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell cultureinfectious intergenotypic chimeric hepatitis C virus. J Virol 81, 629-638.
51. Yi, M., Ma, Y., Yates, J. & Lemon, S. M. (2009). Trans- complementation of an NS2 defect in a late step in hepatitis C virus (HCV) particle assembly and maturation. PLoS Pathog 5, e1000403.
52. You, L. R., Chen, C. M., Yeh, T. S., Tsai, T. Y., Mai, R. T., Lin, C. H. & Lee, Y. H. (1999). Hepatitis C virus core protein interacts with cellular putative RNA helicase. J Virol 73, 2841-2853.
53. Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T. & Chisari, F. V. (2005). Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102, 9294-9299.